Prostaglandin EP1 receptor (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Prostaglandin EP1 receptor" in English language version.

refsWebsite

Global rank English rank

20nih.gov

4^th place

12doi.org

2^nd place

5semanticscholar.org

11^th place

8^th place

2ensembl.org

1,626^th place

1,007^th place

1harvard.edu

18^th place

17^th place

doi.org

Woodward DF, Jones RL, Narumiya S (September 2011). "International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress". Pharmacological Reviews. 63 (3): 471–538. doi:10.1124/pr.110.003517. PMID 21752876.
Ricciotti E, FitzGerald GA (May 2011). "Prostaglandins and inflammation". Arteriosclerosis, Thrombosis, and Vascular Biology. 31 (5): 986–1000. doi:10.1161/ATVBAHA.110.207449. PMC 3081099. PMID 21508345.
Markovič T, Jakopin Ž, Dolenc MS, Mlinarič-Raščan I (January 2017). "Structural features of subtype-selective EP receptor modulators". Drug Discovery Today. 22 (1): 57–71. doi:10.1016/j.drudis.2016.08.003. PMID 27506873.
Narumiya S, Sugimoto Y, Ushikubi F (October 1999). "Prostanoid receptors: structures, properties, and functions". Physiological Reviews. 79 (4): 1193–226. doi:10.1152/physrev.1999.79.4.1193. PMID 10508233. S2CID 7766467.
Korbecki J, Baranowska-Bosiacka I, Gutowska I, Chlubek D (2014). "Cyclooxygenase pathways". Acta Biochimica Polonica. 61 (4): 639–49. doi:10.18388/abp.2014_1825. PMID 25343148.
Moreno JJ (December 2016). "Eicosanoid receptors: Targets for the treatment of disrupted intestinal epithelial homeostasis". European Journal of Pharmacology. 796: 7–19. doi:10.1016/j.ejphar.2016.12.004. PMID 27940058. S2CID 1513449.
Matsuoka T, Narumiya S (August 2008). "The roles of prostanoids in infection and sickness behaviors". Journal of Infection and Chemotherapy. 14 (4): 270–8. doi:10.1007/s10156-008-0622-3. PMID 18709530. S2CID 207058745.
Matsuoka T, Narumiya S (September 2007). "Prostaglandin receptor signaling in disease". TheScientificWorldJournal. 7: 1329–47. doi:10.1100/tsw.2007.182. PMC 5901339. PMID 17767353.
Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA, Kunz A, Cho S, Orio M, Iadecola C (February 2006). "Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity". Nature Medicine. 12 (2): 225–9. doi:10.1038/nm1362. PMID 16432513. S2CID 33649705.
Fischborn SV, Soerensen J, Potschka H (September 2010). "Targeting the prostaglandin E2 EP1 receptor and cyclooxygenase-2 in the amygdala kindling model in mice". Epilepsy Research. 91 (1): 57–65. doi:10.1016/j.eplepsyres.2010.06.012. PMID 20655707. S2CID 36191106.
Khatibi NH, Jadhav V, Matus B, Fathali N, Martin R, Applegate R, Tang J, Zhang JH (2011). "Prostaglandin E2 EP1 Receptor Inhibition Fails to Provide Neuroprotection in Surgically Induced Brain-Injured Mice". Intracerebral Hemorrhage Research. Acta Neurochirurgica Supplementum. Vol. 111. pp. 277–81. doi:10.1007/978-3-7091-0693-8_46. ISBN 978-3-7091-0692-1. PMC 3569069. PMID 21725768. {{cite book}}: |journal= ignored (help)
Glushakov AV, Fazal JA, Narumiya S, Doré S (2014). "Role of the prostaglandin E2 EP1 receptor in traumatic brain injury". PLOS ONE. 9 (11): e113689. Bibcode:2014PLoSO...9k3689G. doi:10.1371/journal.pone.0113689. PMC 4245217. PMID 25426930.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000160951 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000019464 – Ensembl, May 2017

harvard.edu

ui.adsabs.harvard.edu

Glushakov AV, Fazal JA, Narumiya S, Doré S (2014). "Role of the prostaglandin E2 EP1 receptor in traumatic brain injury". PLOS ONE. 9 (11): e113689. Bibcode:2014PLoSO...9k3689G. doi:10.1371/journal.pone.0113689. PMC 4245217. PMID 25426930.

nih.gov

pubmed.ncbi.nlm.nih.gov

Woodward DF, Jones RL, Narumiya S (September 2011). "International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress". Pharmacological Reviews. 63 (3): 471–538. doi:10.1124/pr.110.003517. PMID 21752876.
Ricciotti E, FitzGerald GA (May 2011). "Prostaglandins and inflammation". Arteriosclerosis, Thrombosis, and Vascular Biology. 31 (5): 986–1000. doi:10.1161/ATVBAHA.110.207449. PMC 3081099. PMID 21508345.
Markovič T, Jakopin Ž, Dolenc MS, Mlinarič-Raščan I (January 2017). "Structural features of subtype-selective EP receptor modulators". Drug Discovery Today. 22 (1): 57–71. doi:10.1016/j.drudis.2016.08.003. PMID 27506873.
Narumiya S, Sugimoto Y, Ushikubi F (October 1999). "Prostanoid receptors: structures, properties, and functions". Physiological Reviews. 79 (4): 1193–226. doi:10.1152/physrev.1999.79.4.1193. PMID 10508233. S2CID 7766467.
Korbecki J, Baranowska-Bosiacka I, Gutowska I, Chlubek D (2014). "Cyclooxygenase pathways". Acta Biochimica Polonica. 61 (4): 639–49. doi:10.18388/abp.2014_1825. PMID 25343148.
Moreno JJ (December 2016). "Eicosanoid receptors: Targets for the treatment of disrupted intestinal epithelial homeostasis". European Journal of Pharmacology. 796: 7–19. doi:10.1016/j.ejphar.2016.12.004. PMID 27940058. S2CID 1513449.
Matsuoka T, Narumiya S (August 2008). "The roles of prostanoids in infection and sickness behaviors". Journal of Infection and Chemotherapy. 14 (4): 270–8. doi:10.1007/s10156-008-0622-3. PMID 18709530. S2CID 207058745.
Matsuoka T, Narumiya S (September 2007). "Prostaglandin receptor signaling in disease". TheScientificWorldJournal. 7: 1329–47. doi:10.1100/tsw.2007.182. PMC 5901339. PMID 17767353.
Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA, Kunz A, Cho S, Orio M, Iadecola C (February 2006). "Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity". Nature Medicine. 12 (2): 225–9. doi:10.1038/nm1362. PMID 16432513. S2CID 33649705.
Fischborn SV, Soerensen J, Potschka H (September 2010). "Targeting the prostaglandin E2 EP1 receptor and cyclooxygenase-2 in the amygdala kindling model in mice". Epilepsy Research. 91 (1): 57–65. doi:10.1016/j.eplepsyres.2010.06.012. PMID 20655707. S2CID 36191106.
Khatibi NH, Jadhav V, Matus B, Fathali N, Martin R, Applegate R, Tang J, Zhang JH (2011). "Prostaglandin E2 EP1 Receptor Inhibition Fails to Provide Neuroprotection in Surgically Induced Brain-Injured Mice". Intracerebral Hemorrhage Research. Acta Neurochirurgica Supplementum. Vol. 111. pp. 277–81. doi:10.1007/978-3-7091-0693-8_46. ISBN 978-3-7091-0692-1. PMC 3569069. PMID 21725768. {{cite book}}: |journal= ignored (help)
Glushakov AV, Fazal JA, Narumiya S, Doré S (2014). "Role of the prostaglandin E2 EP1 receptor in traumatic brain injury". PLOS ONE. 9 (11): e113689. Bibcode:2014PLoSO...9k3689G. doi:10.1371/journal.pone.0113689. PMC 4245217. PMID 25426930.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: PTGER1 prostaglandin E receptor 1 (subtype EP1), 42kDa".
"PTGER1 prostaglandin E receptor 1 [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov.
Ricciotti E, FitzGerald GA (May 2011). "Prostaglandins and inflammation". Arteriosclerosis, Thrombosis, and Vascular Biology. 31 (5): 986–1000. doi:10.1161/ATVBAHA.110.207449. PMC 3081099. PMID 21508345.
Matsuoka T, Narumiya S (September 2007). "Prostaglandin receptor signaling in disease". TheScientificWorldJournal. 7: 1329–47. doi:10.1100/tsw.2007.182. PMC 5901339. PMID 17767353.
Khatibi NH, Jadhav V, Matus B, Fathali N, Martin R, Applegate R, Tang J, Zhang JH (2011). "Prostaglandin E2 EP1 Receptor Inhibition Fails to Provide Neuroprotection in Surgically Induced Brain-Injured Mice". Intracerebral Hemorrhage Research. Acta Neurochirurgica Supplementum. Vol. 111. pp. 277–81. doi:10.1007/978-3-7091-0693-8_46. ISBN 978-3-7091-0692-1. PMC 3569069. PMID 21725768. {{cite book}}: |journal= ignored (help)
Glushakov AV, Fazal JA, Narumiya S, Doré S (2014). "Role of the prostaglandin E2 EP1 receptor in traumatic brain injury". PLOS ONE. 9 (11): e113689. Bibcode:2014PLoSO...9k3689G. doi:10.1371/journal.pone.0113689. PMC 4245217. PMID 25426930.

semanticscholar.org

api.semanticscholar.org

Narumiya S, Sugimoto Y, Ushikubi F (October 1999). "Prostanoid receptors: structures, properties, and functions". Physiological Reviews. 79 (4): 1193–226. doi:10.1152/physrev.1999.79.4.1193. PMID 10508233. S2CID 7766467.
Moreno JJ (December 2016). "Eicosanoid receptors: Targets for the treatment of disrupted intestinal epithelial homeostasis". European Journal of Pharmacology. 796: 7–19. doi:10.1016/j.ejphar.2016.12.004. PMID 27940058. S2CID 1513449.
Matsuoka T, Narumiya S (August 2008). "The roles of prostanoids in infection and sickness behaviors". Journal of Infection and Chemotherapy. 14 (4): 270–8. doi:10.1007/s10156-008-0622-3. PMID 18709530. S2CID 207058745.
Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA, Kunz A, Cho S, Orio M, Iadecola C (February 2006). "Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity". Nature Medicine. 12 (2): 225–9. doi:10.1038/nm1362. PMID 16432513. S2CID 33649705.
Fischborn SV, Soerensen J, Potschka H (September 2010). "Targeting the prostaglandin E2 EP1 receptor and cyclooxygenase-2 in the amygdala kindling model in mice". Epilepsy Research. 91 (1): 57–65. doi:10.1016/j.eplepsyres.2010.06.012. PMID 20655707. S2CID 36191106.